Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
FXIA INHIBITOR AND PHARMACEUTICAL COMPOSITION, PREPARATION METHOD AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2022/222960
Kind Code:
A1
Abstract:
Disclosed are a substituted pyridone macrocyclic compound represented by formula I, a pharmaceutical composition and the use thereof. The compound has an FXIa inhibitory effect, good pharmacokinetics and other properties, and can be used for treating diseases related to blood coagulation and preparing drugs for symptoms or diseases, such as preparing anticoagulants and drugs for preventing and/or treating thrombus.

More Like This:
JPH05509293INDUSTRIAL APPLICABILITY The use of 5-HT4 receptor antagonists in the treatment of arrhythmias and seizures.
JP6080227Benzodioxane for checking the Roy Cotrien generation
JP6386088Benzomorphan analogs and their use
Inventors:
LUAN LINBO (CN)
YAO YUANSHAN (CN)
CHEN YONGKAI (CN)
WANG CHAODONG (CN)
Application Number:
PCT/CN2022/087919
Publication Date:
October 27, 2022
Filing Date:
April 20, 2022
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
SHANGHAI MEIYUE BIOTECH DEV CO LTD (CN)
International Classes:
A61K31/439; C07D471/18; A61P7/02
Domestic Patent References:
WO2015116882A12015-08-06
WO2016053455A12016-04-07
WO2015116886A12015-08-06
Attorney, Agent or Firm:
BEIJING ORIGINTELLIGENCE IP LAW FIRM (CN)
Download PDF:
View/Download PDF      PDF Help



 
Previous Patent: PROCESSING DEVICE AND MANUFACTURING METHOD FOR COOLING ELEMENT, AND CIGARETTE PROCESSING SYSTEM

Next Patent: ANTIBODY BINDING CTLA-4 AND USE THEREOF